Research involving applications of artificial intelligence (AI) in health care has expanded rapidly in recent years. In particular, deep learning methods using convolutional neural networks has demonstrated the ability to achieve expert-level performance in image-based diagnosis. Although the highest-profile AI work in ophthalmology has applied this technology to retinal disease, there are several potential applications to corneal pathologic conditions.1,2 Most work to date has focused on keratoconus owing to its high prevalence and primarily image-based diagnosis. Convolutional neural networks have been trained to detect keratoconus from corneal tomographic imaging with high accuracy and also show potential for monitoring progression of disease, but the ability to indicate the risk of postrefractive ectasia or future development of keratoconus remains elusive.3
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Redd TK, Campbell JP, Chiang MF. Artificial Intelligence for Refractive Surgery Screening: Finding the Balance Between Myopia and Hype-ropia. JAMA Ophthalmol. Published online March 26, 2020. doi:10.1001/jamaophthalmol.2020.0515
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: